Carisma Therapeutics Inc. Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31)
Carisma Therapeutics Inc. reported Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) of 60.04% for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-17.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsExpectedVolatilityRate · last filed 2017-11-17
- Carisma Therapeutics Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2017-03-31 was 81.42%, a 4.86% increase year-over-year.
- Carisma Therapeutics Inc. fair value assumptions, expected volatility rate (deprecated 2018-01-31) for the quarter ending 2016-03-31 was 77.65%.
| Period end | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | 60.04% 10-Q · filed 2017-11-17 | ||||
| 2017-06-30 | 73.45% 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | 81.42% 10-Q · filed 2017-05-04 | ||||
| 2016-12-31 | 83.39% 10-Q · filed 2017-11-17 | ||||
| 2016-09-30 | 87.59% 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | 79.43% 10-Q · filed 2016-08-12 | ||||
| 2016-03-31 | 77.65% 10-Q · filed 2016-05-05 | ||||
| 2015-12-31 | 70.67% 10-Q · filed 2016-11-14 | ||||
| 2015-09-30 | 60.05% 10-Q · filed 2015-11-04 | ||||
| 2015-06-30 | 63.17% 10-Q · filed 2015-08-13 | ||||
| 2015-03-31 | 62.19% 10-Q · filed 2015-04-30 | ||||
| 2014-12-31 | 56.79% 10-Q · filed 2015-04-30 | 56.79% 10-Q · filed 2015-11-04 |